Physician profile
Robert H Hartmann
NPI 1265416911
$392,500.83
in general payments reported to CMS, 2019-2025
46 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,308 · 2020: $12K · 2021: $66K · 2022: $154K · 2023: $98K · 2024: $45K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $126K · Travel and Lodging: $23K · Food and Beverage: $3,391 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $820 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $126,436.18 |
| Travel and Lodging | $23,172.73 |
| Food and Beverage | $3,391.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $820.00 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $360,668.83 | 2019-2025 | Acessa Provu System |
| Hologic Sales and Service, LLC | $19,479.92 | 2020-2025 | Acessa Provu System, None, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $2,811.61 | 2021-2022 | |
| Minerva Surgical, INC | $1,838.67 | 2019 | |
| Sumitomo Pharma America, INC. | $1,287.19 | 2023-2025 | Myfembree |
| Olympus Corporation of The Americas | $1,123.80 | 2019-2020 | |
| Meditrina | $715.26 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $680.75 | 2021 | |
| Stryker Corporation | $549.44 | 2020-2022 | |
| Abbvie INC. | $471.08 | 2019-2025 | |
| Astellas Pharma US INC | $326.34 | 2023-2025 | Veozah |
| Amgen INC. | $277.30 | 2020-2025 | Prolia, Evenity, Prolia |
| Evofem Biosciences, INC. | $265.63 | 2021-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $221.48 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $151.77 | 2019-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $150.48 | 2021-2022 | |
| Caldera Medical, INC | $149.00 | 2025 | |
| Ethicon US, LLC | $132.60 | 2024-2025 | Enseal, Harmonic, Enseal X1 |
| Intuitive Surgical, INC. | $111.27 | 2024 | |
| Becton, Dickinson and Company | $92.27 | 2021-2022 | |
| Cytyc Surgical Products, LLC | $85.90 | 2025 | Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $81.69 | 2020-2023 | Injectafer |
| Therapeuticsmd, INC. | $81.37 | 2019-2020 | |
| Coopersurgical, INC. | $76.16 | 2019-2024 | Wallach Cryosurgical Equipment, Paragard T 380a, Paragard T 380a |
| Dysis Medical, INC. | $69.40 | 2021-2022 | |
| Urovant Sciences INC | $67.19 | 2022 | |
| Pfizer INC. | $55.25 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $52.22 | 2022 | |
| Baxter Healthcare | $49.44 | 2025 | Perclot |
| Sage Therapeutics, LLC | $36.18 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $34.74 | 2019-2023 | Ova1 |
| Alexion Pharmaceuticals, INC. | $34.61 | 2019 | |
| Axonics, INC. | $27.50 | 2023 | Axonics, Bulkamid |
| Avion Pharmaceuticals | $25.76 | 2021 | |
| Duchesnay USA Incorporated | $23.92 | 2019 | |
| Exact Sciences Corporation | $23.41 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $21.47 | 2025 | Wegovy |
| Mallinckrodt Enterprises LLC | $19.88 | 2019 | |
| Merck Sharp & Dohme LLC | $19.01 | 2019 | |
| Scynexis, INC. | $18.31 | 2022 | |
| Exeltis, USA INC. | $18.21 | 2025 | Slynd |
| Covidien Lp | $17.60 | 2020 | |
| Smith+Nephew, INC. | $16.49 | 2025 | Pico 14 |
| Conmed Corporation | $14.57 | 2025 | Airseal |
| Pacira Pharmaceuticals Incorporated | $13.45 | 2020 | |
| Lupin INC. | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hartmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.